Q
QUMEA
Provides a unique solution for discreet patient monitoring
About QUMEA
QUMEA is a health tech startup that provides an advanced system for fall prevention and mobility monitoring in hospitals and care facilities. The company's unique sensor technology and intelligent software continuously monitor each patient's activity and mobility, automatically calling for help based on the individual needs of each patient. This proactive risk management approach helps healthcare professionals improve patient outcomes and reduce the workload significantly.
QUMEA's system is particularly beneficial in acute geriatrics, where it has been praised for providing a high level of patient safety without infringing on privacy. The system has been successful in reducing falls and improving patient outcomes, with one test recording a 67% reduction in falls. Importantly, QUMEA's system is 100% anonymous and does not use cameras or microphones, ensuring patient privacy is maintained.
The company's business model revolves around selling its technology to healthcare institutions. It generates revenue from the sale of its sensor technology and software, and possibly from ongoing service and maintenance contracts. The market for QUMEA's product is vast, given the global need for effective fall prevention and mobility monitoring in healthcare settings.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- Solothurn, Switzerland
- Employees
- 66
- Open positions
- 3
- Dealroom signal
- 89.3/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Remote Monitoring, Core AI, Tech for Patients, Silver Economy
- Technology
- Artificial Intelligence, Hardware, 3D Technology, Deep Tech, Machine Learning
- Business model
- Manufacturing, SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GROWTH EQUITY VCOther financing | Oct 2025 | $0 | — | GRO Capital | ↗ |
| DEBTDebt | Jan 2024 | $0 | — | UBS | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for QUMEA is 4.7K monthly website visits, up 46.9% over the last three months. QUMEA's team grew 40.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Business Angels Switzerland
Series A2 investors entered at this stage
ZKB - Zürcher Kantonalbank- PIPB Invest
Series B and later2 investors entered at this stage
UBS
GRO Capital
Other known investors1 additional known investor
VentureLab
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about QUMEA on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See QUMEA’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.